Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,745–3,752 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Rocket Pharmaceuticals Inc. RP-L301 Pyruvate Kinase Deficiency (PKD) Phase 2 Ongoing Intravenous Genetic Disorder
Rocket Pharmaceuticals Inc. RP-A501 Danon disease Phase 2 Hold Removed Intravenous Genetic Disorder
Rocket Pharmaceuticals Inc. Trabodenoson and latanoprost Glaucoma Phase 2 Trial Discontinued Ocular Opthalmic
Roivant Sciences Ltd. Brepocitinib - (NEPTUNE) Non-infectious uveitis (NIU) Phase 3 Data Released Oral Opthalmic
Roivant Sciences Ltd. Batoclimab Thyroid Eye Disease (TED) Phase 3 Ongoing Intravenous Opthalmic
Roivant Sciences Ltd. Batoclimab Myasthenia Gravis (MG) Phase 3 Data Released Intravenous Neurology
Roivant Sciences Ltd. ADORING 2 Atopic Dermatitis Phase 3 Data Released Oral Immunology
Roivant Sciences Ltd. Batoclimab Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) Phase 2b Data Released Intravenous Neurology